Trial Profile
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- Acronyms Btx-HT
- 09 Nov 2023 Primary endpoint (clinical state improvement of patients evaluated by the Clinical Global Impression of Change (CGI)) has been met according results published in the New England Journal of Medicine
- 09 Nov 2023 Results published in the New England Journal of Medicine
- 08 Dec 2022 Status changed from recruiting to completed.